Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Wright

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|October 6, 2018
Impact of a pharmacist-led diabetes management on outcomes, utilization, and costDaniel D Maeng, Jove Graham, Michael Bogart, et al.
Research in Social & Administrative Pharmacy : RSAP|May 2, 2024
Impact of cost on prescribing diabetes medications for older adults with type 2 diabetes in the outpatient settingMia E Lussier, Ravi J Desai, Eric A Wright, et al.
Journal of General Internal Medicine|October 2, 2023
Factors Affecting Prescribing of Type 2 Diabetes Medications in Older Adults within an Integrated Healthcare SystemMia E Lussier, Michael R Gionfriddo, Jove H Graham, et al.
Journal of the American Pharmacists Association : Japha|July 25, 2021
Informing collaborative relationships between community pharmacists and health care professionals in primary care practicesYardlee S Kauffman, Eric A Wright, Brandon J Patterson, et al.
The Pharmacogenomics Journal|October 2, 2025
An innovative model for pharmacogenomics critical results identification and interventionRyley Uber, Vanessa A Hayduk, Alison Flango, et al.
Journal of the American Pharmacists Association : Japha|August 29, 2024
Qualitative evaluation to understand barriers and facilitators to prescribing angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose cotransporter inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF)Apoorva M Pradhan, Mia E Lussier, My Nguyen, et al.
Plos One|December 2, 2021
A mixed methods evaluation of medication reconciliation in the primary care settingMichael R Gionfriddo, Vanessa Duboski, Allison Middernacht, et al.
Educational and Psychological Measurement|November 3, 2022
Assessing Ability Recovery of the Sequential IRT Model With Unstructured Multiple-Attempt DataZiying Li, A Corinne Huggins-Manley, Walter L Leite, et al.
Plos One|June 28, 2016
Absolute Cerebral Blood Flow Infarction Threshold for 3-Hour Ischemia Time Determined with CT Perfusion and 18F-FFMZ-PET Imaging in a Porcine Model of Cerebral IschemiaEric A Wright, Christopher D d'Esterre, Laura B Morrison, et al.
Pharmacogenomics|November 15, 2023
Pre-emptive pharmacogenomics implementation among polypharmacy patients 65 years old and older: a clinical pilotRyley Uber, Vanessa A Hayduk, Apoorva Pradhan, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Clinicoeconomics and Outcomes Research : CEOR|October 6, 2018
Impact of a pharmacist-led diabetes management on outcomes, utilization, and costDaniel D Maeng, Jove Graham, Michael Bogart, et al.
Research in Social & Administrative Pharmacy : RSAP|May 2, 2024
Impact of cost on prescribing diabetes medications for older adults with type 2 diabetes in the outpatient settingMia E Lussier, Ravi J Desai, Eric A Wright, et al.
Journal of General Internal Medicine|October 2, 2023
Factors Affecting Prescribing of Type 2 Diabetes Medications in Older Adults within an Integrated Healthcare SystemMia E Lussier, Michael R Gionfriddo, Jove H Graham, et al.
Journal of the American Pharmacists Association : Japha|July 25, 2021
Informing collaborative relationships between community pharmacists and health care professionals in primary care practicesYardlee S Kauffman, Eric A Wright, Brandon J Patterson, et al.
The Pharmacogenomics Journal|October 2, 2025
An innovative model for pharmacogenomics critical results identification and interventionRyley Uber, Vanessa A Hayduk, Alison Flango, et al.
Journal of the American Pharmacists Association : Japha|August 29, 2024
Qualitative evaluation to understand barriers and facilitators to prescribing angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose cotransporter inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF)Apoorva M Pradhan, Mia E Lussier, My Nguyen, et al.
Plos One|December 2, 2021
A mixed methods evaluation of medication reconciliation in the primary care settingMichael R Gionfriddo, Vanessa Duboski, Allison Middernacht, et al.
Educational and Psychological Measurement|November 3, 2022
Assessing Ability Recovery of the Sequential IRT Model With Unstructured Multiple-Attempt DataZiying Li, A Corinne Huggins-Manley, Walter L Leite, et al.
Plos One|June 28, 2016
Absolute Cerebral Blood Flow Infarction Threshold for 3-Hour Ischemia Time Determined with CT Perfusion and 18F-FFMZ-PET Imaging in a Porcine Model of Cerebral IschemiaEric A Wright, Christopher D d'Esterre, Laura B Morrison, et al.
Pharmacogenomics|November 15, 2023
Pre-emptive pharmacogenomics implementation among polypharmacy patients 65 years old and older: a clinical pilotRyley Uber, Vanessa A Hayduk, Apoorva Pradhan, et al.
Pageof 5